These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38113333)

  • 1. RHOA
    Schaefer A; Hodge RG; Zhang H; Hobbs GA; Dilly J; Huynh MV; Goodwin CM; Zhang F; Diehl JN; Pierobon M; Baldelli E; Javaid S; Guthrie K; Rashid NU; Petricoin EF; Cox AD; Hahn WC; Aguirre AJ; Bass AJ; Der CJ
    Sci Signal; 2023 Dec; 16(816):eadg5289. PubMed ID: 38113333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gain-of-Function
    Zhang H; Schaefer A; Wang Y; Hodge RG; Blake DR; Diehl JN; Papageorge AG; Stachler MD; Liao J; Zhou J; Wu Z; Akarca FG; de Klerk LK; Derks S; Pierobon M; Hoadley KA; Wang TC; Church G; Wong KK; Petricoin EF; Cox AD; Lowy DR; Der CJ; Bass AJ
    Cancer Discov; 2020 Feb; 10(2):288-305. PubMed ID: 31771969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RHOA drivers take alternate routes in gastric cancer.
    Benton D; Chernoff J
    Sci Signal; 2023 Dec; 16(816):eadk9171. PubMed ID: 38113334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer.
    Zhang F; Sahu V; Peng K; Wang Y; Li T; Bala P; Aitymbayev D; Sahgal P; Schaefer A; Der CJ; Ryeom S; Yoon S; Sethi N; Bass AJ; Zhang H
    Gut; 2024 Jul; 73(8):1280-1291. PubMed ID: 38621923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.
    Cho SY; Park JW; Liu Y; Park YS; Kim JH; Yang H; Um H; Ko WR; Lee BI; Kwon SY; Ryu SW; Kwon CH; Park DY; Lee JH; Lee SI; Song KS; Hur H; Han SU; Chang H; Kim SJ; Kim BS; Yook JH; Yoo MW; Kim BS; Lee IS; Kook MC; Thiessen N; He A; Stewart C; Dunford A; Kim J; Shih J; Saksena G; Cherniack AD; Schumacher S; Weiner AT; Rosenberg M; Getz G; Yang EG; Ryu MH; Bass AJ; Kim HK
    Gastroenterology; 2017 Aug; 153(2):536-549.e26. PubMed ID: 28522256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo effects of mutant RHOA on tumor formation in an orthotopic inoculation model.
    Nishizawa T; Nakano K; Fujii E; Komura D; Kuroiwa Y; Ishimaru C; Monnai M; Aburatani H; Ishikawa S; Suzuki M
    Oncol Rep; 2019 Nov; 42(5):1745-1754. PubMed ID: 31485674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAS and RHO family GTPase mutations in cancer: twin sons of different mothers?
    Hodge RG; Schaefer A; Howard SV; Der CJ
    Crit Rev Biochem Mol Biol; 2020 Aug; 55(4):386-407. PubMed ID: 32838579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhoA G17E/Vav1 Signaling Induces Cancer Invasion via Matrix Metalloproteinase-9 in Gastric Cancer.
    Nakamura S; Kitazawa M; Miyagawa Y; Koyama M; Miyazaki S; Hondo N; Muranaka F; Tokumaru S; Yamamoto Y; Ehara T; Matsumura T; Takeoka M; Soejima Y
    Technol Cancer Res Treat; 2023; 22():15330338221146024. PubMed ID: 36617975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Rho(d) Map to Diffuse Gastric Cancer.
    Benton D; Chernoff J
    Cancer Discov; 2020 Feb; 10(2):182-184. PubMed ID: 32024682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant alternative splicing of RHOA is associated with loss of its expression and activity in diffuse-type gastric carcinoma cells.
    Miyamoto S; Nagamura Y; Nakabo A; Okabe A; Yanagihara K; Fukami K; Sakai R; Yamaguchi H
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1942-1947. PubMed ID: 29247652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma.
    Kakiuchi M; Nishizawa T; Ueda H; Gotoh K; Tanaka A; Hayashi A; Yamamoto S; Tatsuno K; Katoh H; Watanabe Y; Ichimura T; Ushiku T; Funahashi S; Tateishi K; Wada I; Shimizu N; Nomura S; Koike K; Seto Y; Fukayama M; Aburatani H; Ishikawa S
    Nat Genet; 2014 Jun; 46(6):583-7. PubMed ID: 24816255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological characteristics of RHOA mutations in a Central European gastric cancer cohort.
    Röcken C; Behrens HM; Böger C; Krüger S
    J Clin Pathol; 2016 Jan; 69(1):70-5. PubMed ID: 26251521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARHGAP-RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer.
    Komatsu M; Ichikawa H; Chiwaki F; Sakamoto H; Komatsuzaki R; Asaumi M; Tsunoyama K; Fukagawa T; Matsushita H; Boku N; Matsusaki K; Takeshita F; Yoshida T; Sasaki H
    Oncogene; 2022 Oct; 41(43):4779-4794. PubMed ID: 36127398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho guanosine 5'-triphosphatases differentially regulate insulin-like growth factor I (IGF-I) receptor-dependent and -independent actions of IGF-II on human trophoblast migration.
    Shields SK; Nicola C; Chakraborty C
    Endocrinology; 2007 Oct; 148(10):4906-17. PubMed ID: 17640993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Met-dependent phosphorylation of RhoA plays a key role in gastric cancer tumorigenesis.
    Liu J; Li S; Chen S; Chen S; Geng Q; Xu D
    J Pathol; 2019 Sep; 249(1):126-136. PubMed ID: 31056743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin engagement differentially modulates epithelial cell motility by RhoA/ROCK and PAK1.
    Zhou H; Kramer RH
    J Biol Chem; 2005 Mar; 280(11):10624-35. PubMed ID: 15611088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DGC-specific
    Nishizawa T; Nakano K; Harada A; Kakiuchi M; Funahashi SI; Suzuki M; Ishikawa S; Aburatani H
    Oncotarget; 2018 May; 9(33):23198-23207. PubMed ID: 29796182
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of RhoA GTP hydrolysis by the GTPase-activating proteins p190, p50RhoGAP, Bcr, and 3BP-1.
    Zhang B; Zheng Y
    Biochemistry; 1998 Apr; 37(15):5249-57. PubMed ID: 9548756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins.
    Liu BP; Burridge K
    Mol Cell Biol; 2000 Oct; 20(19):7160-9. PubMed ID: 10982832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic mutations on Rac1 affect global intrinsic dynamics underlying GTP and PAK1 binding.
    Acuner SE; Sumbul F; Torun H; Haliloglu T
    Biophys J; 2021 Mar; 120(5):866-876. PubMed ID: 33515600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.